These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19535382)

  • 1. Using HIV resistance tests in clinical practice.
    Taylor S; Jayasuriya A; Smit E
    J Antimicrob Chemother; 2009 Aug; 64(2):218-22. PubMed ID: 19535382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV susceptibility testing--time for standards.
    Hill AM; Telenti A
    Antivir Ther; 2004 Aug; 9(4):463-4. PubMed ID: 15456076
    [No Abstract]   [Full Text] [Related]  

  • 6. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV resistance testing: methods, utility, and limitations.
    Alcorn TM; Faruki H
    Mol Diagn; 2000 Sep; 5(3):159-68. PubMed ID: 11070150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the difference between phenotyping and genotyping?
    Wilder TL
    Surviv News (Atlanta Ga); 2001 May; ():13, 20. PubMed ID: 11682727
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.
    AIDS Alert; 2003 Nov; 18(11):146-7. PubMed ID: 14674368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 11. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV resistance testing benefit is shown.
    AIDS Alert; 2001 Oct; 16(10):136. PubMed ID: 11590937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tests to detect resistance to antiretroviral agents in clinical practice].
    Seriano Vázquez V; Rodríguez-Rosado y Martínez-Echevarría R; Martínez-Echevarría
    Rev Clin Esp; 1999 Mar; 199(3):179-83. PubMed ID: 10230303
    [No Abstract]   [Full Text] [Related]  

  • 14. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolving role of antiretroviral drug resistance testing in HIV-infected individuals.
    Idemyor V
    HIV Clin Trials; 2002; 3(5):413-7. PubMed ID: 12407491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV resistance: frequency, testing, mechanisms.
    Kuritzkes DR
    Top HIV Med; 2007; 15(5):150-4. PubMed ID: 18073450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Raymond S; Delobel P; Izopet J
    J Antimicrob Chemother; 2010 Sep; 65(9):2056-7; author reply 2058-9. PubMed ID: 20554569
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinically validated genotype analysis: guiding principles and statistical concerns.
    Brun-Vézinet F; Costagliola D; Khaled MA; Calvez V; Clavel F; Clotet B; Haubrich R; Kempf D; King M; Kuritzkes D; Lanier R; Miller M; Miller V; Phillips A; Pillay D; Schapiro J; Scott J; Shafer R; Zazzi M; Zolopa A; DeGruttola V
    Antivir Ther; 2004 Aug; 9(4):465-78. PubMed ID: 15456077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing gains shown in antiretroviral resistance. Research addresses new recommendations.
    AIDS Alert; 2003 Sep; 18(9):114-7. PubMed ID: 14686306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.